<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Nevada National Board Professional Learning Institute | Gibbs | Activity</title>
	<link>http://www.nationalboardinstitute.com/members/findswitch3/activity/</link>
	<atom:link href="http://www.nationalboardinstitute.com/members/findswitch3/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Gibbs.</description>
	<lastBuildDate>Fri, 23 May 2025 17:06:54 -0700</lastBuildDate>
	<generator>https://buddypress.org/?v=9.1.1</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">7c30b434296eba8b91812116104e7c13</guid>
				<title>Gibbs posted an update: PURPOSE To provide an overview of fibroblast growth factor [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/42024/</link>
				<pubDate>Sat, 08 Feb 2025 11:54:16 -0800</pubDate>

									<content:encoded><![CDATA[<p>PURPOSE To provide an overview of fibroblast growth factor receptor (FGFR) gene alterations and the pharmacology, clinical effectiveness, dosage and administration, cost, and place in therapy of erdafitinib in bladder cancer. SUMMARY Erdafitinib (Balversa, Janssen Pharmaceuticals) is a novel pan-FGFR inhibitor recently approved for the treatment&hellip;<span class="activity-read-more" id="activity-read-more-42024"><a href="http://www.nationalboardinstitute.com/activity/p/42024/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">55442c637dc805beafe9f93979b05392</guid>
				<title>Gibbs posted an update: We study the spin-orbit interaction of two-dimensional [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/40455/</link>
				<pubDate>Thu, 06 Feb 2025 16:29:54 -0800</pubDate>

									<content:encoded><![CDATA[<p>We study the spin-orbit interaction of two-dimensional electron/hole gas (2DEGs/2DHGs) on quasi-2D potassium niobates (KNs) via first-principles calculations. The strong surface polarity changes the free surface states from 2DEGs to 2DHGs. The in-plane dipole maintained on 2D models leads to giant Zeeman-type spin splitting, as high as 566 meV f&hellip;<span class="activity-read-more" id="activity-read-more-40455"><a href="http://www.nationalboardinstitute.com/activity/p/40455/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">36fcaf1965cc36f161821c31d18378a0</guid>
				<title>Gibbs posted an update: New findings of immune and metabolic defects in type 1 [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/38549/</link>
				<pubDate>Tue, 04 Feb 2025 11:53:00 -0800</pubDate>

									<content:encoded><![CDATA[<p>New findings of immune and metabolic defects in type 1 diabetes that can be corrected with repeat BCG vaccination suggest that this therapeutic strategy may be applicable in other diseases with inadequate aerobic glycolysis, including Parkinson&#8217;s disease, dementia, depression and other disorders affecting the nervous system. © 2020 The&hellip;<span class="activity-read-more" id="activity-read-more-38549"><a href="http://www.nationalboardinstitute.com/activity/p/38549/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a7640efcde57f97d6ad1b7b707fa9100</guid>
				<title>Gibbs posted an update: BACKGROUND As artificial intelligence (AI) approaches in [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/35800/</link>
				<pubDate>Sat, 01 Feb 2025 11:25:57 -0800</pubDate>

									<content:encoded><![CDATA[<p>BACKGROUND As artificial intelligence (AI) approaches in research increase and AI becomes more integrated into medicine, there is a need to understand perspectives from members of the Canadian public and medical community. The aim of this project was to investigate current perspectives on ethical issues surrounding AI in health care. <a href="https://www.selleckchem.com/products/ew-7197.html" rel="nofollow ugc">TEW-7197&hellip;</a><span class="activity-read-more" id="activity-read-more-35800"><a href="http://www.nationalboardinstitute.com/activity/p/35800/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d77ae2069ef07e6e8450a2c699486a3f</guid>
				<title>Gibbs posted an update: There is a clear clinical need for a better understanding of [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/33949/</link>
				<pubDate>Thu, 30 Jan 2025 11:25:17 -0800</pubDate>

									<content:encoded><![CDATA[<p>There is a clear clinical need for a better understanding of the biological underpinnings of major depressive disorder (MDD), allowing for the development of a treatment that is targeted to pathophysiology. Recent data indicate a role for the endogenous opioidergic system in MDD. This article reviews the roles and physiological interactions of the&hellip;<span class="activity-read-more" id="activity-read-more-33949"><a href="http://www.nationalboardinstitute.com/activity/p/33949/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">d85d9306c67fe9263f1103f0a1f88b0f</guid>
				<title>Gibbs posted an update: between body image distress and depressive symptoms and [&#133;]</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30965/</link>
				<pubDate>Tue, 28 Jan 2025 15:59:54 -0800</pubDate>

									<content:encoded><![CDATA[<p>between body image distress and depressive symptoms and social functioning.</p>
<p> Despite promising achievements in precision cancer medicine (PCM), participating patients are still faced with manifold uncertainties, especially regarding a potential treatment benefit of molecular diagnostics (MD). Hence, MD poses considerable challenges for patient&hellip;<span class="activity-read-more" id="activity-read-more-30965"><a href="http://www.nationalboardinstitute.com/activity/p/30965/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">9e23ef7e63c96dfabe5c45e81942e3cb</guid>
				<title>Gibbs became a registered member</title>
				<link>http://www.nationalboardinstitute.com/activity/p/30945/</link>
				<pubDate>Tue, 28 Jan 2025 15:58:22 -0800</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>